Form 4 ARDELYX, INC. For: Feb 20 Filed by: GRAMMER ELIZABETH A

Go back to Form 4 ARDELYX, INC. For: Feb 20 Filed by: GRAMMER ELIZABETH A

Ardelyx, Inc (ARDX) PT Raised to $13 at H.C. Wainwright

February 23, 2024 6:08 AM EST

H.C. Wainwright analyst Ed Arce raised the price target on Ardelyx, Inc (NASDAQ: ARDX) to $13.00 (from $11.00) while maintaining a Buy rating.

The analyst comments "We project U.S. IBSRELA annual net sales growth of 84% in 2024. Yesterday, Ardelyx announced 2023 U.S. IBSRELA net sales for irritable bowel syndrome (IBS-C) of $80.1M, largely in-line with... More